Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-03-26 | 95411 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-18 | 2022-09-08 | 167159 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2025-11-27 | 2025-12-13 | 272751 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2020-03-12 | 2020-03-26 | 108610 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2022-12-01 | 2023-07-05 | 176767 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2025-05-15 | 2025-07-03 | 257521 |
| NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2025-05-22 | 2025-07-18 | 258118 |
| NOVAMOXIN | 500MG | CAPSULE | Resolved | 2020-04-16 | 2020-05-08 | 112364 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
| NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-07-09 | 109604 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-04-03 | 2017-05-23 | 5165 |
| NOVO-CYPROTERONE/ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2017-04-25 | 2017-09-19 | 8068 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2019-06-27 | 2020-03-19 | 87680 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2022-08-18 | 2022-09-23 | 167229 |
| NOVO-GESIC | 325MG | TABLET | Resolved | 2020-03-26 | 2020-05-21 | 109571 |
| NOVO-GESIC FORTE | 500MG | TABLET | Resolved | 2020-04-10 | 2020-06-04 | 111829 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |